MetaCap

Teva Pharmaceutical Industries Insider Trades

NYSE: TEVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

41.10+1.85 (+4.71%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

After hours: 41.22 +0.30%

Last 12 months

Purchases
0 · $0
Sales
23 · $37.79M
Shares bought / sold
0 / 1.04M
Net activity
Net selling $37.8 million

Teva Pharmaceutical Industries insider activity

Over the last 12 months, Teva Pharmaceutical Industries insiders reported 43 transactions on SEC Form 4: 0 open-market purchases and 23 sales. Insiders bought $0 and sold $37.8 million worth of stock, for net insider selling of $37.8 million. The largest seller was MIGNONE ROBERTO, with $14.4 million in reported sales.

The most recent filing shows Savage Brian (Interim Chief Legal Officer) reporting a transaction in 4,503 shares at $34.70 on Sep 18, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TEVA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TEVA insider transactions

Teva Pharmaceutical Industries insider transactions
DateInsiderTypeSharesValueFiling
Sep 18, 2026MIGNONE ROBERTODirectorSale367,600$14.36MForm 4
Sep 18, 2026Savage BrianInterim Chief Legal OfficerSale314$12.15KForm 4
Sep 18, 2026Savage BrianInterim Chief Legal OfficerSale2,525$98.84KForm 4
Sep 18, 2026Savage BrianInterim Chief Legal OfficerSale4,503$174.22KForm 4
Sep 18, 2026Savage BrianInterim Chief Legal OfficerOption exercise4,503$156.25KForm 4
Aug 21, 2026Satchi-Fainaro RonitDirectorSale415$15.46KForm 4
Aug 21, 2026Weiss AmirChief Accounting OfficerSale2,500$94.08KForm 4
Aug 21, 2026Weiss AmirChief Accounting OfficerOption exercise2,500$49.02KForm 4
Aug 21, 2026Weiss AmirChief Accounting OfficerSale6,945$261.22KForm 4
Aug 17, 2026Lippman EvanEVP, Business DevelopmentSale18,600$680.29KForm 4
Aug 5, 2026Zaks Tal ZviDirectorSale17$592.71Form 4
Aug 3, 2026Hughes Eric ASee "Remarks"Sale25,578$892.05KForm 4
Aug 3, 2026Hughes Eric ASee "Remarks"Option exercise52,744—Form 4
Aug 3, 2026Jover PlacidSee "Remarks"Sale12,827$447.35KForm 4
Aug 3, 2026Jover PlacidSee "Remarks"Option exercise12,827—Form 4
Jun 18, 2026Shields MatthewEVP, Global OperationsSale9,989$321.55KForm 4
Jun 11, 2026Kalif Eliyahu SharonEVP, Chief Financial OfficerSale106,563$3.63MForm 4
Jun 5, 2026Zaks Tal ZviDirectorOption exercise14,492—Form 4
Jun 5, 2026Nisen PerryDirectorOption exercise14,492—Form 4
Jun 5, 2026Francis Richard DPresident and CEOSale6,153$211.36KForm 4
Jun 5, 2026Francis Richard DPresident and CEOOption exercise13,043—Form 4
Jun 5, 2026MIGNONE ROBERTODirectorOption exercise14,492—Form 4
Jun 5, 2026Elstein AmirDirectorOption exercise14,492—Form 4
Jun 5, 2026Satchi-Fainaro RonitDirectorOption exercise14,492—Form 4
Jun 5, 2026Lichtenstein ChenDirectorOption exercise14,492—Form 4
Jun 5, 2026LIEBERMAN GERALD MDirectorOption exercise14,492—Form 4
Jun 5, 2026BARER SOL JDirectorOption exercise21,739—Form 4
Jun 5, 2026Crane Rosemary ADirectorOption exercise14,492—Form 4
Jun 3, 2026Shields MatthewEVP, Global OperationsSale16,195$532.33KForm 4
Jun 3, 2026Shields MatthewEVP, Global OperationsOption exercise16,195—Form 4
May 14, 2026Kalif Eliyahu SharonEVP, Chief Financial OfficerSale153,251$5.46MForm 4
May 14, 2026Lippman EvanEVP, Business DevelopmentSale35,912$1.28MForm 4
May 14, 2026Lippman EvanEVP, Business DevelopmentOption exercise74,008—Form 4
May 14, 2026Lippman EvanEVP, Business DevelopmentSale5,746$204.47KForm 4
May 14, 2026Lippman EvanEVP, Business DevelopmentOption exercise11,841—Form 4
May 6, 2026Weiss AmirChief Accounting OfficerSale10,679$384.44KForm 4
May 5, 2026Daniell RichardEVP, Europe CommercialSale30,000$1.06MForm 4
May 1, 2026Sabag MarkSee "Remarks"Sale144,180$5.05MForm 4
Apr 30, 2026Fox ChristineEVP, U.S. CommercialSale21,258$750.62KForm 4
Mar 17, 2026Sabag MarkSee "Remarks"Sale62,102$1.87MForm 4
Mar 5, 2026Weiss AmirChief Accounting OfficerOption exercise3,537—Form 4
Mar 5, 2026Sabag MarkSee "Remarks"Option exercise15,723—Form 4
Mar 5, 2026Kalif Eliyahu SharonEVP, Chief Financial OfficerOption exercise19,916—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related